Establishment Labs Holdings Stock Buy Hold or Sell Recommendation
| ESTA Stock | USD 45.55 2.47 5.73% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Establishment Labs Holdings is 'Strong Sell'. Macroaxis provides Establishment Labs buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ESTA positions.
Check out Establishment Labs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Establishment and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Establishment |
Execute Establishment Labs Buy or Sell Advice
The Establishment recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Establishment Labs Holdings. Macroaxis does not own or have any residual interests in Establishment Labs Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Establishment Labs' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Establishment Labs Trading Alerts and Improvement Suggestions
| Establishment Labs had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 165.15 M. Net Loss for the year was (78.5 M) with profit before overhead, payroll, taxes, and interest of 106.59 M. | |
| Establishment Labs Holdings currently holds about 65.35 M in cash with (88.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68. | |
| Establishment Labs has a very weak financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Establishment Labs Holdings Inc. Shares Sold by GSA Capital Partners LLP - MarketBeat |
Establishment Labs Returns Distribution Density
The distribution of Establishment Labs' historical returns is an attempt to chart the uncertainty of Establishment Labs' future price movements. The chart of the probability distribution of Establishment Labs daily returns describes the distribution of returns around its average expected value. We use Establishment Labs Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Establishment Labs returns is essential to provide solid investment advice for Establishment Labs.
| Mean Return | 0.09 | Value At Risk | -7.22 | Potential Upside | 8.20 | Standard Deviation | 4.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Establishment Labs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Establishment Stock Institutional Investors
| Shares | Polar Capital Holdings Plc | 546.5 K | Bamco Inc | 2024-09-30 | 489.4 K | Balyasny Asset Management Llc | 2024-09-30 | 480.2 K | Sofinnova Ventures | 2024-06-30 | 429.2 K | First Turn Management Llc | 2024-09-30 | 357 K | Mudita Advisors Llp | 2024-09-30 | 354.8 K | Divisadero Street Capital Management, Lp | 2024-09-30 | 341.1 K | Boothbay Fund Management, Llc | 2024-09-30 | 311.1 K | Affinity Asset Advisors, Llc | 2024-09-30 | 290.4 K | Jw Asset Management, Llc | 2024-09-30 | 3.2 M | Rtw Investments, Llc | 2024-06-30 | 2.7 M |
Establishment Labs Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (3.4M) | 4.8M | (7.6M) | (10.9M) | (42.2M) | (40.1M) | |
| Investments | (7.8M) | (5.6M) | (7.2M) | (34.8M) | (24.5M) | (23.3M) | |
| Change In Cash | (15.0M) | 46.9M | (31.1M) | 12.9M | (26.3M) | (25.0M) | |
| Net Borrowings | 24.5M | (277K) | (175K) | 96.4M | 110.9M | 116.4M | |
| Free Cash Flow | (37.0M) | (16.4M) | (34.3M) | (86.4M) | (112.4M) | (106.8M) | |
| Depreciation | 3.3M | 3.7M | 4.1M | 4.3M | 4.9M | 3.5M | |
| Other Non Cash Items | 2.2M | 1.4M | 5.5M | 26.8M | 8.6M | 8.2M | |
| Capital Expenditures | 7.0M | 3.9M | 6.7M | 34.3M | 24.5M | 12.3M | |
| Net Income | (38.2M) | (38.1M) | (41.1M) | (75.2M) | (78.5M) | (74.6M) | |
| End Period Cash Flow | 37.7M | 84.5M | 53.4M | 66.4M | 40.0M | 47.6M | |
| Change To Netincome | 7.1M | 2.2M | 13.8M | 22.1M | 25.4M | 26.6M |
Establishment Labs Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Establishment Labs or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Establishment Labs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Establishment stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | 1.80 | |
σ | Overall volatility | 4.62 | |
Ir | Information ratio | -0.009 |
Establishment Labs Volatility Alert
Establishment Labs Holdings exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Establishment Labs' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Establishment Labs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Establishment Labs Fundamentals Vs Peers
Comparing Establishment Labs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Establishment Labs' direct or indirect competition across all of the common fundamentals between Establishment Labs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Establishment Labs or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Establishment Labs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Establishment Labs by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Establishment Labs to competition |
| Fundamentals | Establishment Labs | Peer Average |
| Return On Equity | -2.23 | -0.31 |
| Return On Asset | -0.12 | -0.14 |
| Profit Margin | (0.46) % | (1.27) % |
| Operating Margin | (0.33) % | (5.51) % |
| Current Valuation | 1.4 B | 16.62 B |
| Shares Outstanding | 28.76 M | 571.82 M |
| Shares Owned By Insiders | 11.27 % | 10.09 % |
| Shares Owned By Institutions | 98.62 % | 39.21 % |
| Number Of Shares Shorted | 5.12 M | 4.71 M |
| Price To Earning | (20.11) X | 28.72 X |
| Price To Book | 37.88 X | 9.51 X |
| Price To Sales | 8.10 X | 11.42 X |
| Revenue | 165.15 M | 9.43 B |
| Gross Profit | 106.59 M | 27.38 B |
| EBITDA | (58.31 M) | 3.9 B |
| Net Income | (78.5 M) | 570.98 M |
| Cash And Equivalents | 65.35 M | 2.7 B |
| Cash Per Share | 2.68 X | 5.01 X |
| Total Debt | 192.22 M | 5.32 B |
| Current Ratio | 4.27 X | 2.16 X |
| Book Value Per Share | 1.16 X | 1.93 K |
| Cash Flow From Operations | (88.51 M) | 971.22 M |
| Short Ratio | 10.82 X | 4.00 X |
| Earnings Per Share | (2.59) X | 3.12 X |
| Target Price | 60.29 | |
| Number Of Employees | 908 | 18.84 K |
| Beta | 1.21 | -0.15 |
| Market Capitalization | 1.24 B | 19.03 B |
| Total Asset | 268.64 M | 29.47 B |
| Retained Earnings | (360.1 M) | 9.33 B |
| Working Capital | 117.75 M | 1.48 B |
| Current Asset | 60.91 M | 9.34 B |
| Current Liabilities | 45.78 M | 7.9 B |
Note: Acquisition by Lewin Nicholas Sheridan of 2345 shares of Establishment Labs subject to Rule 16b-3 [view details]
Establishment Labs Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Establishment . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 34221.94 | |||
| Daily Balance Of Power | 1.012295 | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 44.75 | |||
| Day Typical Price | 45.02 | |||
| Price Action Indicator | 2.03 | |||
| Period Momentum Indicator | 2.47 |
About Establishment Labs Buy or Sell Advice
When is the right time to buy or sell Establishment Labs Holdings? Buying financial instruments such as Establishment Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Establishment Labs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Establishment Labs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Revenue Per Share 5.58 | Quarterly Revenue Growth 0.045 | Return On Assets (0.12) | Return On Equity (2.23) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.